MYC inhibition in melanoma: Preclinical promise and the unveiling of a prognostic gene signature
Cutaneous melanoma, the most aggressive form of skin cancer, is the fifth most diagnosed cancer in Europe and one of the most frequent causes of cancer death, with incidence and mortality trends on the rise. While the development ...
Apr 20, 2023
0
2